The Case for a New National Program for the Development of Cancer Therapeutics
- 15 June 2001
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 19 (12) , 3142-3153
- https://doi.org/10.1200/jco.2001.19.12.3142
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Tyrosine-kinase inhibition in treatment of chronic myeloid leukaemiaThe Lancet, 2000
- Clinical development of platinum complexes in cancer therapy: an historical perspective and an updateEuropean Journal Of Cancer, 1998
- An Information-Intensive Approach to the Molecular Pharmacology of CancerScience, 1997
- Revisions of general guidelines for the preclinical toxicology of new cytotoxic anticancer agents in EuropeEuropean Journal Of Cancer, 1995
- Promotion of microtubule assembly in vitro by taxolNature, 1979
- The evaluation of anticancer drugs in dogs and monkeys for the prediction of qualitative toxicities in manClinical Pharmacology & Therapeutics, 1970
- Inhibition of Cell Division in Escherichia coli by Electrolysis Products from a Platinum ElectrodeNature, 1965